report-image

Global Biopharmaceutical Contract Manufacturings Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 10/11/2022
  • NO OF PAGES
  • 221
  • CATEGORY
  • Others
The Biopharmaceutical Contract Manufacturings market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Biopharmaceutical Contract Manufacturings market. On the basis of historic growth analysis and current scenario of Biopharmaceutical Contract Manufacturings market place, the report intends to offer actionable insights and outlook on global / regional market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tool that facilitate deeper understanding of multiple aspects of global Biopharmaceutical Contract Manufacturings market. These further helps users with their developmental strategy.

This report examines all the key factors influencing growth of global Biopharmaceutical Contract Manufacturings market, including demand-supply scenario, pricing structure, profit margins, production and value chain / ecosystem analysis. Regional assessment of global Biopharmaceutical Contract Manufacturings market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.



Global Biopharmaceutical Contract Manufacturings Market: Major Players
Patheon Inc.
Boehringer Ingelheim
Recipharm AB
Catalent Inc.
Baxter Biopharma Solutions
Famar
Pfizer Centresource
Cambrex Corporation
Lonza
Jubilant Life Sciences Ltd.
Aenova
Abbvie Inc.

Global Biopharmaceutical Contract Manufacturings Market: By Types
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development & Manufacturing
Others

Global Biopharmaceutical Contract Manufacturings Market: By Applications
Oncology
Central Nervous System
Cardiovascular Disorders
Infectious Diseases
Pulmonary Disorders
Metabolic Disorders
Others



Global Biopharmaceutical Contract Manufacturings Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Biopharmaceutical Contract Manufacturings market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Global Biopharmaceutical Contract Manufacturings Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035


1 Biopharmaceutical Contract Manufacturings Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Biopharmaceutical Contract Manufacturings
1.3 Biopharmaceutical Contract Manufacturings Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Biopharmaceutical Contract Manufacturings
1.4.2 Applications of Biopharmaceutical Contract Manufacturings
1.5 Market Exchange Rate

2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source

3 Market Competition Analysis
3.1 Patheon Inc. Market Performance Analysis
3.1.1 Patheon Inc. Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 Patheon Inc. Sales, Value, Price, Gross Margin 2016-2021
3.2 Boehringer Ingelheim Market Performance Analysis
3.2.1 Boehringer Ingelheim Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Boehringer Ingelheim Sales, Value, Price, Gross Margin 2016-2021
3.3 Recipharm AB Market Performance Analysis
3.3.1 Recipharm AB Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Recipharm AB Sales, Value, Price, Gross Margin 2016-2021
3.4 Catalent Inc. Market Performance Analysis
3.4.1 Catalent Inc. Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Catalent Inc. Sales, Value, Price, Gross Margin 2016-2021
3.5 Baxter Biopharma Solutions Market Performance Analysis
3.5.1 Baxter Biopharma Solutions Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Baxter Biopharma Solutions Sales, Value, Price, Gross Margin 2016-2021
3.6 Famar Market Performance Analysis
3.6.1 Famar Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Famar Sales, Value, Price, Gross Margin 2016-2021
3.7 Pfizer Centresource Market Performance Analysis
3.7.1 Pfizer Centresource Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 Pfizer Centresource Sales, Value, Price, Gross Margin 2016-2021
3.8 Cambrex Corporation Market Performance Analysis
3.8.1 Cambrex Corporation Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Cambrex Corporation Sales, Value, Price, Gross Margin 2016-2021
3.9 Lonza Market Performance Analysis
3.9.1 Lonza Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Lonza Sales, Value, Price, Gross Margin 2016-2021
3.10 Jubilant Life Sciences Ltd. Market Performance Analysis
3.10.1 Jubilant Life Sciences Ltd. Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Jubilant Life Sciences Ltd. Sales, Value, Price, Gross Margin 2016-2021
3.11 Aenova Market Performance Analysis
3.11.1 Aenova Basic Information
3.11.2 Product and Service Analysis
3.11.3 Strategies for Company to Deal with the Impact of COVID-19
3.11.4 Aenova Sales, Value, Price, Gross Margin 2016-2021
3.12 Abbvie Inc. Market Performance Analysis
3.12.1 Abbvie Inc. Basic Information
3.12.2 Product and Service Analysis
3.12.3 Strategies for Company to Deal with the Impact of COVID-19
3.12.4 Abbvie Inc. Sales, Value, Price, Gross Margin 2016-2021

4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Biopharmaceutical Contract Manufacturings Production and Value by Type
4.1.1 Global Biopharmaceutical Contract Manufacturings Production by Type 2016-2021
4.1.2 Global Biopharmaceutical Contract Manufacturings Market Value by Type 2016-2021
4.2 Global Biopharmaceutical Contract Manufacturings Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Active Pharmaceutical Ingredient (API) Manufacturing Market Production, Value and Growth Rate
4.2.2 Finished Dosage Formulation (FDF) Development & Manufacturing Market Production, Value and Growth Rate
4.2.3 Others Market Production, Value and Growth Rate
4.3 Global Biopharmaceutical Contract Manufacturings Production and Value Forecast by Type
4.3.1 Global Biopharmaceutical Contract Manufacturings Production Forecast by Type 2022-2030
4.3.2 Global Biopharmaceutical Contract Manufacturings Market Value Forecast by Type 2022-2030
4.4 Global Biopharmaceutical Contract Manufacturings Market Production, Value and Growth Rate by Type Forecast 2022-2030
4.4.1 Active Pharmaceutical Ingredient (API) Manufacturing Market Production, Value and Growth Rate Forecast
4.4.2 Finished Dosage Formulation (FDF) Development & Manufacturing Market Production, Value and Growth Rate Forecast
4.4.3 Others Market Production, Value and Growth Rate Forecast

5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Biopharmaceutical Contract Manufacturings Consumption and Value by Application
5.1.1 Global Biopharmaceutical Contract Manufacturings Consumption by Application 2016-2021
5.1.2 Global Biopharmaceutical Contract Manufacturings Market Value by Application 2016-2021
5.2 Global Biopharmaceutical Contract Manufacturings Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Oncology Market Consumption, Value and Growth Rate
5.2.2 Central Nervous System Market Consumption, Value and Growth Rate
5.2.3 Cardiovascular Disorders Market Consumption, Value and Growth Rate
5.2.4 Infectious Diseases Market Consumption, Value and Growth Rate
5.2.5 Pulmonary Disorders Market Consumption, Value and Growth Rate
5.2.6 Metabolic Disorders Market Consumption, Value and Growth Rate
5.2.7 Others Market Consumption, Value and Growth Rate
5.3 Global Biopharmaceutical Contract Manufacturings Consumption and Value Forecast by Application
5.3.1 Global Biopharmaceutical Contract Manufacturings Consumption Forecast by Application 2022-2030
5.3.2 Global Biopharmaceutical Contract Manufacturings Market Value Forecast by Application 2022-2030
5.4 Global Biopharmaceutical Contract Manufacturings Market Consumption, Value and Growth Rate by Application Forecast 2022-2030
5.4.1 Oncology Market Consumption, Value and Growth Rate Forecast
5.4.2 Central Nervous System Market Consumption, Value and Growth Rate Forecast
5.4.3 Cardiovascular Disorders Market Consumption, Value and Growth Rate Forecast
5.4.4 Infectious Diseases Market Consumption, Value and Growth Rate Forecast
5.4.5 Pulmonary Disorders Market Consumption, Value and Growth Rate Forecast
5.4.6 Metabolic Disorders Market Consumption, Value and Growth Rate Forecast
5.4.7 Others Market Consumption, Value and Growth Rate Forecast

6 Global Biopharmaceutical Contract Manufacturings by Region, Historical Data and Market Forecasts
6.1 Global Biopharmaceutical Contract Manufacturings Sales by Region 2016-2021
6.2 Global Biopharmaceutical Contract Manufacturings Market Value by Region 2016-2021
6.3 Global Biopharmaceutical Contract Manufacturings Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Biopharmaceutical Contract Manufacturings Sales Forecast by Region 2022-2030
6.5 Global Biopharmaceutical Contract Manufacturings Market Value Forecast by Region 2022-2030
6.6 Global Biopharmaceutical Contract Manufacturings Market Sales, Value and Growth Rate Forecast by Region 2022-2030
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa

7 United State Market Size Analysis 2016-2030
7.1 United State Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
7.2 United State Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
7.3 United State Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

8 Canada Market Size Analysis 2016-2030
8.1 Canada Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
8.2 Canada Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
8.3 Canada Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

9 Germany Market Size Analysis 2016-2030
9.1 Germany Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
9.2 Germany Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
9.3 Germany Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

10 UK Market Size Analysis 2016-2030
10.1 UK Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
10.2 UK Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
10.3 UK Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

11 France Market Size Analysis 2016-2030
11.1 France Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
11.2 France Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
11.3 France Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

12 Italy Market Size Analysis 2016-2030
12.1 Italy Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
12.2 Italy Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
12.3 Italy Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

13 Spain Market Size Analysis 2016-2030
13.1 Spain Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
13.2 Spain Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
13.3 Spain Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

14 Russia Market Size Analysis 2016-2030
14.1 Russia Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
14.2 Russia Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
14.3 Russia Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

15 China Market Size Analysis 2016-2030
15.1 China Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
15.2 China Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
15.3 China Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

16 Japan Market Size Analysis 2016-2030
16.1 Japan Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
16.2 Japan Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
16.3 Japan Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

17 South Korea Market Size Analysis 2016-2030
17.1 South Korea Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
17.2 South Korea Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
17.3 South Korea Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

18 Australia Market Size Analysis 2016-2030
18.1 Australia Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
18.2 Australia Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
18.3 Australia Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

19 Thailand Market Size Analysis 2016-2030
19.1 Thailand Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
19.2 Thailand Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
19.3 Thailand Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

20 Brazil Market Size Analysis 2016-2030
20.1 Brazil Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
20.2 Brazil Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
20.3 Brazil Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

21 Argentina Market Size Analysis 2016-2030
21.1 Argentina Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
21.2 Argentina Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
21.3 Argentina Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

22 Chile Market Size Analysis 2016-2030
22.1 Chile Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
22.2 Chile Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
22.3 Chile Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

23 South Africa Market Size Analysis 2016-2030
23.1 South Africa Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
23.2 South Africa Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
23.3 South Africa Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

24 Egypt Market Size Analysis 2016-2030
24.1 Egypt Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
24.2 Egypt Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
24.3 Egypt Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

25 UAE Market Size Analysis 2016-2030
25.1 UAE Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
25.2 UAE Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
25.3 UAE Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

26 Saudi Arabia Market Size Analysis 2016-2030
26.1 Saudi Arabia Biopharmaceutical Contract Manufacturings Value and Market Growth 2016-2021
26.2 Saudi Arabia Biopharmaceutical Contract Manufacturings Sales and Market Growth 2016-2021
26.3 Saudi Arabia Biopharmaceutical Contract Manufacturings Market Value Forecast 2022-2030

27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI